Literature DB >> 26232890

Effect of Plasma Fibrinogen, High-Sensitive C-Reactive Protein, and Cigarette Smoking on Carotid Atherosclerosis: The Suita Study.

Kayoko Kawase Ishihara1, Yoshihiro Kokubo2, Chiaki Yokota3, Eisuke Hida4, Toshiyuki Miyata5, Kazunori Toyoda6, Masayasu Matsumoto7, Kazuo Minematsu6, Yoshihiro Miyamoto2.   

Abstract

BACKGROUND: Few studies have reported on the association between inflammatory markers and atherosclerosis by smoking status. We investigated the effect of plasma levels of fibrinogen and high-sensitive C-reactive protein (hsCRP) on subclinical atherosclerosis stratified by smoking in a general urban population.
METHODS: From participants of the Suita study without a history of cardiovascular diseases, a total of 2502 subjects (805 men, median age 64 years) who underwent carotid ultrasonography were enrolled. Subjects were divided into current smokers (n = 566) and never-smokers. Ex-smokers were not included in the study. Each group was subdivided according to the median levels of markers (plasma fibrinogen [2.99 g/L] and hsCRP [.51 mg/L]) and the smoking amounts. We compare the adjusted maximum and mean intima-media thickness (IMT).
RESULTS: In men and women, maximum IMT and mean IMT of the high fibrinogen and high hsCRP (Fib(H)CRP(H)) with smoking were thicker than those of the low fibrinogen and low hsCRP (Fib(L)CRP(L)) without smoking, the Fib(L)CRP(L) with smoking, and the Fib(H)CRP(H) without smoking after adjusting for covariates. The Fib(L)CRP(L) with smoking had thicker IMTs than the Fib(L)CRP(L) without smoking. There was a dose-dependent smoking effect on IMT in men. These trends were similar in age 60, 65, and 70.
CONCLUSIONS: Plasma fibrinogen and hsCRP levels were related to multivariate-adjusted IMT, and smoking was associated with IMT in men. The combination of plasma fibrinogen and hsCRP levels could be a potential marker on subclinical carotid atherosclerosis in urban people.
Copyright © 2015 National Stroke Association. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Intima–media thickness; inflammatory marker; plaque; risk factors

Mesh:

Substances:

Year:  2015        PMID: 26232890     DOI: 10.1016/j.jstrokecerebrovasdis.2015.06.039

Source DB:  PubMed          Journal:  J Stroke Cerebrovasc Dis        ISSN: 1052-3057            Impact factor:   2.136


  14 in total

1.  Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017.

Authors:  Makoto Kinoshita; Koutaro Yokote; Hidenori Arai; Mami Iida; Yasushi Ishigaki; Shun Ishibashi; Seiji Umemoto; Genshi Egusa; Hirotoshi Ohmura; Tomonori Okamura; Shinji Kihara; Shinji Koba; Isao Saito; Tetsuo Shoji; Hiroyuki Daida; Kazuhisa Tsukamoto; Juno Deguchi; Seitaro Dohi; Kazushige Dobashi; Hirotoshi Hamaguchi; Masumi Hara; Takafumi Hiro; Sadatoshi Biro; Yoshio Fujioka; Chizuko Maruyama; Yoshihiro Miyamoto; Yoshitaka Murakami; Masayuki Yokode; Hiroshi Yoshida; Hiromi Rakugi; Akihiko Wakatsuki; Shizuya Yamashita
Journal:  J Atheroscler Thromb       Date:  2018-08-22       Impact factor: 4.928

2.  Combined Oral Contraceptives Increase High-Sensitivity C-Reactive Protein but Not Haptoglobin in Female Athletes.

Authors:  Sabina Cauci; Maria Pia Francescato; Francesco Curcio
Journal:  Sports Med       Date:  2017-01       Impact factor: 11.136

3.  Red blood cell distribution width and carotid intima-media thickness in patients with metabolic syndrome.

Authors:  Dongdong Ren; Juan Wang; Hua Li; Yanyan Li; Zhanzhan Li
Journal:  BMC Cardiovasc Disord       Date:  2017-01-28       Impact factor: 2.298

4.  Association between Coagulation Function and Cerebral Microbleeds in Ischemic Stroke Patients with Atrial Fibrillation and/or Rheumatic Heart Disease.

Authors:  Junfeng Liu; Deren Wang; Yao Xiong; Bian Liu; Jing Lin; Shihong Zhang; Bo Wu; Chenchen Wei; Ming Liu
Journal:  Aging Dis       Date:  2017-04-01       Impact factor: 6.745

5.  Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: protocol of a randomised controlled proof-of-concept trial (APPLE COPD-ICON 2).

Authors:  Vijay Kunadian; Danny Chan; Hani Ali; Nina Wilkinson; Nicola Howe; Elaine McColl; Jared Thornton; Alexander von Wilamowitz-Moellendorff; Eva-Maria Holstein; Graham Burns; Andrew Fisher; Deborah Stocken; Anthony De Soyza
Journal:  BMJ Open       Date:  2018-05-26       Impact factor: 2.692

6.  A Pilot Study Providing Evidence for a Relationship between a Composite Lifestyle Score and Risk of Higher Carotid Intima-Media Thickness: Is There a Link to Oxidative Stress?

Authors:  Neda Seyedsadjadi; Jade Berg; Ayse A Bilgin; Ross Grant
Journal:  Oxid Med Cell Longev       Date:  2018-04-26       Impact factor: 6.543

7.  Antiplatelet therapy in the primary prevention of cardiovascular disease in patients with chronic obstructive pulmonary disease: a randomised controlled proof-of-concept trial.

Authors:  Vijay Kunadian; Nina Wilson; Deborah D Stocken; Hani Ali; Elaine McColl; Graham Burns; Nicola Howe; Andrew Fisher; Anthony De Soyza
Journal:  ERJ Open Res       Date:  2019-08-05

8.  Early Markers of Atherosclerotic Disease in Individuals with Excess Weight and Dyslipidemia.

Authors:  Eduardo Menti; Denise Zaffari; Thais Galarraga; João Regis da Conceição E Lessa; Bruna Pontin; Lucia Campos Pellanda; Vera Lúcia Portal
Journal:  Arq Bras Cardiol       Date:  2016-05-03       Impact factor: 2.000

Review 9.  Causes of changes in carotid intima-media thickness: a literature review.

Authors:  Baoge Qu; Tao Qu
Journal:  Cardiovasc Ultrasound       Date:  2015-12-15       Impact factor: 2.062

10.  Effects of cigarette smoking on coagulation screening tests and platelet counts in a Sudanese male adults population.

Authors:  Ahmed M Elkhalifa
Journal:  Saudi Med J       Date:  2018-09       Impact factor: 1.484

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.